These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 738768)

  • 1. Influence of a synthetic adjuvant (MDP) on qualitative and quantitative changes of serum globulins.
    Leclerc C; Audibert F; Chedid L
    Immunology; 1978 Dec; 35(6):963-70. PubMed ID: 738768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between chemical structure and adjuvant activity of some synthetic analogues of N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP).
    Audibert F; Chedid L; Lefrancier P; Choay J; Lederer E
    Ann Immunol (Paris); 1977; 128C(3):653-61. PubMed ID: 869513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. I. Effect on the antibody response to bovine serum albumin and sheep red blood cells of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):426-34. PubMed ID: 6248282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
    Bomford R
    Clin Exp Immunol; 1980 Feb; 39(2):435-41. PubMed ID: 6248283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of the humoral and cellular immune response of guinea pigs after injection of the synthetic adjuvant N-acetylmuramyl L-alanyl-D-isoglutamine: comparison with Freund complete adjuvant.
    Souvannavong V; Adam A; Lederer E
    Infect Immun; 1978 Mar; 19(3):966-71. PubMed ID: 346491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological studies of lipophilic MDP-derivatives incorporated in liposomes.
    Jolivet M; Sache E; Audibert F
    Immunol Commun; 1981; 10(6):511-22. PubMed ID: 7319546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
    Lowy I; Theze J; Chedid L
    J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of adaptive immunity by different adjuvant-antigen combinations in mice lacking Nod2.
    Moreira LO; Smith AM; DeFreitas AA; Qualls JE; El Kasmi KC; Murray PJ
    Vaccine; 2008 Oct; 26(46):5808-13. PubMed ID: 18789992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic influences on the adjuvanticity of muramyl dipeptide in vivo.
    Staruch MJ; Wood DD
    J Immunol; 1982 Jan; 128(1):155-60. PubMed ID: 6976368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse.
    Parant M; Parant F; Chedid L; Yapo A; Petit JF; Lederer E
    Int J Immunopharmacol; 1979; 1(1):35-41. PubMed ID: 551094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired stimulation of anti-bovine serum albumin IgG antibodies by vaccine adjuvants in murine acquired immunodeficiency syndrome.
    Phillips NC
    FEMS Microbiol Immunol; 1992 Apr; 4(4):209-18. PubMed ID: 1599706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse.
    Habjanec L; Halassy B; Tomasić J
    Int Immunopharmacol; 2010 Jul; 10(7):751-9. PubMed ID: 20403461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of indomethacin on various immunopharmacological effects of muramyl dipeptide (MDP).
    Parant M; Riveau G; Chedid L
    Agents Actions Suppl; 1980; 7():33-40. PubMed ID: 6941684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules.
    Kotani S; Watanabe Y; Kinoshita F; Morisaki I; Kato K
    Biken J; 1977 Jun; 20(2):39-45. PubMed ID: 588232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity.
    Arnon R; Sela M; Parant M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6769-72. PubMed ID: 6935684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
    Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
    Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of muramyl peptides for the enhancement of synthetic vaccines.
    Chedid L; Audibert F; Jolivet M
    Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide.
    Durette PL; Dorn CP; Friedman A; Schlabach A
    J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.